Answer
The most commonly reported adverse reactions to eprosartan mesilate in clinical trials were headache (approximately 11%) and nonspecific gastrointestinal complaints (approximately 8%); headache did not occur more frequently than with placebo.
Sources for this answer
- Teveten 600 mg Film-coated TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.8 Undesirable effects · Version 35Document updated
Sources checked